Worth reading
63In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
3000000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Monthly exercise status of stock acquisition rights with an exercise price adjustment clause
発行・処分する株式数3,000,000Shares
3,000,000 new shares
発行済株式総数
1.69% (exercise ratio subject to the exercise restriction)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
The exercise price from 13 October to 30 October 2026 was ¥40, ¥38 or ¥35. Details of the exercise-price adjustment provision and the adjustment floor are Not disclosed
Number of Stock Acquisition Rights
Total issued: 800,000 rights; exercised during the month: 30,000 rights; unexercised at month-end: 770,000 rights
Most recent equity financing
Issuance of Series 11 stock acquisition rights with an exercise-price adjustment provision, based on the resolution of 25 September 2026. Amount: Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly exercise status of stock acquisition rights with an exercise price adjustment clause |
| Number of shares to be issued or disposed of | 3,000,000 new shares |
| Dilution Rate | 1.69% (exercise ratio subject to the exercise restriction) |
| Total number of issued shares | 177,722,409 shares (as of the end of the month preceding the month covered) → Not disclosed |
| Exercise price | The exercise price from 13 October to 30 October 2026 was ¥40, ¥38 or ¥35. Details of the exercise-price adjustment provision and the adjustment floor are Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 800,000 rights; exercised during the month: 30,000 rights; unexercised at month-end: 770,000 rights |
| Most recent equity financing | Issuance of Series 11 stock acquisition rights with an exercise-price adjustment provision, based on the resolution of 25 September 2026. Amount: Not disclosed |
Items this document does not state (21)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status. No information is provided on the use of proceeds or the reasons for exercise.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.